About

Alexandre Grassin is Senior Vice President, Head of Finance at HiFiBiO Therapeutics. He is a seasoned biotech finance executive with over 25 years of international experience across the U.S. and Europe, spanning both private and public companies.

Alex has supported multiple equity and debt financings and played a central role in bringing companies to the public markets on Euronext and Nasdaq through reverse takeovers (RTO) and SPAC transactions, as well as in M&A exits. At HiFiBiO, he oversees global finance and accounting and works closely with the executive team to support strategic planning, financial discipline, and long-term value creation.

Prior to HiFiBiO, Alex served as CFO or interim CFO for several biotech and medtech companies, including Genkyotex, Aleva Neurotherapeutics, and enGene, and held senior finance roles at Alexion and Novartis. He began his career at KPMG in audit.

Alex holds a degree in International Management and is based in Boston.